SORT BY Relevancy
March is Myeloma Awareness month and we are exploring the allo transplant therapy route for myeloma patients in our talk with Dr. Bensinger. Why are allogeneic stem cell transplants risky for multiple myeloma patients? When does possible benefit outweigh the risks? RSVP to participate by asking a myeloma question LIVE on the talk to our panel of experts and patients. To mark the Myeloma month of awareness, we have extended our show time by 15 mins where we will have Sarah Kaufmann-Fink of MMore joining us to talk about MMores new research and crowdfunding venture.
This show is part of the Leukemia & Lymphoma Society Patient Education Series.
Our special guest is Dr. Christopher Yasenchak from Compass Oncology in Portland, Oregon. Dr. Yasenchak received his M.D. from Pennsylvania State University. He continued his training at the Mayo Clinic College of Medicine and is board certified in hematology, medical oncology and internal medicine. His clinical focus is multiple myeloma, lymphoma, stem cell transplantation, gastrointestinal malignancies and clinical trials.
Myeloma presents itself with different features in each patient. In order to understand your disease and monitor it, you need to know which are the tests available and how often you have to get the tests done. No single test or study is adequate to tell the whole story about a patient's status, but when used together, test results can give a complete picture. Our experienced myeloma panel is talking to Dr. Joseph Mikhael about understanding your myeloma, types of diagnostic tests and their frequency.
Dr. Joseph Mikhael is a hematologist/oncologist at the Mayo Clinic in Arizona where he researches, teaches and treats multiple myeloma and related conditions. After completing medical school and residency at the University of Ottawa, he completed a second residency and fellowship at the University of Toronto and the Princess Margaret Hospital in Toronto, Ontario. At the Mayo Clinic, Dr. Mikhael is a principal investigator for clinical trials in both relapsed/refractory and newly diagnosed multiple myeloma.
This show is part of the Leukemia & Lymphoma Society Patient Education Series. Our special guest is Dr. Christopher Yasenchak from Compass Oncology in Portland, Oregon. Dr. Yasenchak received his M.D. from Pennsylvania State University. He continued his training at the Mayo Clinic College of Medicine and is board certified in hematology, medical oncology and internal medicine. His clinical focus is multiple myeloma, lymphoma, stem cell transplantation, gastrointestinal malignancies and clinical trials.
Dr. Don Benson, MD, PhD of The James Cancer Center at Ohio State University is a multiple myeloma specialist with deep expertise in immunotherapy. He shares the growing and exciting world of immunotherapies in multiple myeloma - how they work and how they are opening up an exciting new set of opportunities for myeloma patients.
New developments for multiple myeloma are happening at an ever increasing pace. Dr. Ola Landgren is Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center and heavily involved in the direction of myeloma research, both nationally and internationally. In this show he will give a wrap up of the recent Rome International Myeloma Working Group meeting as well as an ASH preview (for the upcoming December conference). He will also share up and coming clinical trials at Memorial Sloan Kettering Cancer Center to incorporate these new treatments into clinical practice. Learn what new drugs will be available and how they can be used in the myeloma clinic.
We are talking about high-risk multiple myeloma and its prognosis with Dr. Sagar Lonial this August. Make sure REGISTER in advance to ask Dr. Lonial your myeloma question.
Dr. Lonial is Professor at the Winship Cancer Institute of Emory University, Director of Translational Research, B-cell malignancy program as well as Associate Director of Hematology Oncology Fellowship Program. He staffs and works both on the transplant service as well as in the B-cell malignancy clinic. Dr. Lonial completed his Hematology-Oncology training at Emory University, and prior to that received his internal medicine residency at the Baylor College of Medicine in Houston Texas. There he spent an additional year as a Chief Medical Resident at the Ben Taub General Hospital as well as the Texas Heart Institute and St Lukes Hospital. Dr. Lonial is on the editorial board for Clinical Lymphoma and Myeloma and The American Journal of Clinical Oncology, as well as an ad hoc reviewer for Blood, Cancer Research, Clinical Cancer Research, Haematologica, and other journals. He has authored or co-authored over 40 papers and abstracts, and was recently appointed to Vice-chair for the ECOG myeloma committee.
Treatment for multiple myeloma is all about the combinations. Recently we've been hearing about the "BIRD" combinations. What are they and how effective are they? Learn from Dr. Tomer Mark, MD, MSc from Weill Cornell Medical Center about this new combination and what it means for myeloma patients.
With the explosion in immunotherapies for multiple myeloma, we have heard there are "windows" of best and most effective use. What are those windows and when is the best time to use these new approaches? The field is ever growing and Dr. Djordje Atanackovic will share how and when to use these new tools for a myeloma patient's best care.
Thanks to our episode sponsor, Takeda Oncology
Enjoy more of Kathy Strong's story and pictures on our website!
Immunotherapies are making their way into the clinic and as they do, more exciting options will be available for patients. Researchers are now studying the best possible way to leverage the standard and effective multiple myeloma treatments with ways to empower the immune system to fight myeloma. Learn what Dr. Daniel Fowler, MD of the NIH is doing to use a Th1 and Th2 immune therapy treatment in combination with stem cell transplant in an early clinical trial.
Special thanks to our Myeloma Crowd Radio episode sponsor, Amgen.
Join Host Live Chats
- Hagmann and Hagmann Report (35 chatters)
- HINDSIGHT RADIO (24 chatters)
- Radio Jihad Network (15 chatters)
- KAS1 (10 chatters)
- LindaCrystal (7 chatters)
- PwtorchEastCoastCast (7 chatters)
- Tarhaka (6 chatters)
- TalkNAngels (5 chatters)
- NatureofReality (4 chatters)
- PROPHETenergyreaderBrenda (3 chatters)
- Frat House Sports (3 chatters)
- HadIt Veteran To Veteran (3 chatters)
- Joseph Gibson (3 chatters)
- Father Teresa (2 chatters)
- MyViewMatters (2 chatters)
- Naked Departure Talk Show (2 chatters)
- No-Tea with Chrita and Cryss (1 chatters)
- Nu Power Radio Network (1 chatters)
- real talk for real people0 (1 chatters)
- Spoken Ink (1 chatters)
- The Huddle (1 chatters)
- VinnyHardy (1 chatters)
- Men Lets Talk (1 chatters)
- MKSPCG (1 chatters)
- Intro to Info (1 chatters)
- JASmius (1 chatters)
- Among The Realms Radio (1 chatters)
- Barry Secrest (1 chatters)
- Body of Christ (1 chatters)
- Comfy Crystal and Medium Eshne (1 chatters)
- Young Black and Empowered (0 chatters)